{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:16:39Z","timestamp":1790907399718,"version":"4.1.0"},"reference-count":134,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.dld.2006.11.004","type":"journal-article","created":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T21:29:55Z","timestamp":1172784595000},"page":"293-304","source":"Crossref","is-referenced-by-count":273,"title":["Herbal medicine in the treatment of liver diseases"],"prefix":"10.1016","volume":"39","author":[{"given":"F.","family":"Stickel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Schuppan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2006.11.004_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/jhep.2002.34734","article-title":"Burden of liver disease in the United States: summary of a workshop","volume":"36","author":"Kim","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2006.11.004_bib2","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1056\/NEJMra020398","article-title":"Herbal remedies","volume":"347","author":"De Smet","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2006.11.004_bib3","doi-asserted-by":"crossref","first-page":"262","DOI":"10.7326\/0003-4819-135-4-200108210-00011","article-title":"Long-term trends in the use of complementary and alternative medical therapies in the United States","volume":"135","author":"Kessler","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2006.11.004_bib4","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1111\/j.1572-0241.2002.05993.x","article-title":"Use of complementary and alternative medicine in patients with liver disease","volume":"97","author":"Strader","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2006.11.004_bib5","first-page":"2654","article-title":"The use of neuropathic remedies for chronic liver disease","volume":"91","author":"Flora","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2006.11.004_bib6","first-page":"49","article-title":"The U.S. botanical market\u2014an overview","volume":"36","author":"Breevort","year":"1996","journal-title":"Herbalogramm"},{"key":"10.1016\/j.dld.2006.11.004_bib7","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1515\/znb-1976-0630","article-title":"Silydianin und Silychristin, zwei isomere Silymarine aus Silybum marianum (Mariendistel)","volume":"31","author":"Wagner","year":"1976","journal-title":"Z Naturforsch"},{"key":"10.1016\/j.dld.2006.11.004_bib8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0041-008X(78)90091-1","article-title":"Effects of penicillin and silymarin on liver enzymes and blood clotting factors in dogs given a boiled preparation of Amanita phalloides","volume":"46","author":"Floersheim","year":"1978","journal-title":"Toxicol Appl Pharamcol"},{"key":"10.1016\/j.dld.2006.11.004_bib9","doi-asserted-by":"crossref","first-page":"12562","DOI":"10.1016\/S0021-9258(18)67125-X","article-title":"Alpha-amanitin uptake into hepatocytes","volume":"261","author":"Kroncke","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1016\/j.dld.2006.11.004_bib10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0041-008X(84)90087-5","article-title":"Protection by silybinin against amanita phalloides intoxication in beagles","volume":"73","author":"Vogel","year":"1984","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.dld.2006.11.004_bib11","first-page":"1","article-title":"Treatment of human amatoxin poisoning: myths and advances in therapy","volume":"2","author":"Floersheim","year":"1987","journal-title":"Med Toxicol Advers Drug Exp"},{"key":"10.1016\/j.dld.2006.11.004_bib12","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/hep.510230415","article-title":"Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin","volume":"23","author":"Dehmlow","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2006.11.004_bib13","first-page":"1383","article-title":"Effects of silibinin and of a synthetic analogue on a isolated rat hepatic stellate cells and myofibroblasts","volume":"12","author":"Fuchs","year":"1997","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.dld.2006.11.004_bib14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1472-8206.1989.tb00449.x","article-title":"Prevention of CC14-induced liver cirrhosis by silymarin","volume":"3","author":"Mourelle","year":"1989","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.dld.2006.11.004_bib15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1440-1746.1994.tb01719.x","article-title":"The pathology of liver injury induced by the chronic administration of alcohol and low dose carbon tetrachloride in Porton rats","volume":"9","author":"Hall","year":"1994","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2006.11.004_bib16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/hep.510260316","article-title":"Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats","volume":"26","author":"Boigk","year":"1997","journal-title":"Hepatology"},{"issue":"suppl.","key":"10.1016\/j.dld.2006.11.004_bib17","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1002\/(SICI)1099-1573(1998)12:1+<S42::AID-PTR245>3.0.CO;2-4","article-title":"Effect of antifibrotic agent silymarin on liver cell regeneration in a rat model of secondary bilary fibrosis: a morphometric analysis","volume":"12","author":"Boigk","year":"1998","journal-title":"J Phytother Res"},{"issue":"suppl.","key":"10.1016\/j.dld.2006.11.004_bib18","first-page":"546A","article-title":"Silymarin downregulates TIMP-1 and collagen I mRNA in rats with secondary biliary cirrhosis","volume":"28","author":"Jia","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2006.11.004_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0168-8278(89)90083-4","article-title":"Randomized controlled clinical trial of silymarin treatment in patients with cirrhosis of the liver","volume":"9","author":"Ferenci","year":"1989","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2006.11.004_bib20","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0168-8278(98)80285-7","article-title":"Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial","volume":"28","author":"Pares","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2006.11.004_bib21","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0002-9343(02)01244-5","article-title":"Milk thistle for the treatment of liver diseases: a systematic review and meta-analysis","volume":"113","author":"Jacobs","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.dld.2006.11.004_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.dld.2006.11.004_bib23","first-page":"1060","article-title":"Zur Wirkung von Silymarin bei der Behandlung der akuten Virushepatitis","volume":"73","author":"Magliulo","year":"1978","journal-title":"Med Klin"},{"key":"10.1016\/j.dld.2006.11.004_bib24","first-page":"5589","article-title":"Double blind trial of silymarin sodium in toxic liver damage","volume":"30","author":"Fintelmann","year":"1980","journal-title":"Therapiewoche"},{"key":"10.1016\/j.dld.2006.11.004_bib25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3109\/00365528209182242","article-title":"Effect of silymarin on chemical, functional, and morphological alterations of the liver. A double-blind controlled study","volume":"17","author":"Salmi","year":"1982","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2006.11.004_bib26","first-page":"311","article-title":"Use of the Romanian product Silimarina in the treatment of chronic liver diseases","volume":"26","author":"Tanasescu","year":"1988","journal-title":"Med Intern"},{"key":"10.1016\/j.dld.2006.11.004_bib27","first-page":"120","article-title":"Treatment of alcoholic hepatitis with silymarin. A double-blind comparative study in 116 patients","volume":"13","author":"Trinchet","year":"1989","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.dld.2006.11.004_bib28","first-page":"1370","article-title":"Controlled study of the effect of silymarin on alcoholic liver disease","volume":"120","author":"Bunout","year":"1992","journal-title":"Rev Med Chil"},{"key":"10.1016\/j.dld.2006.11.004_bib29","first-page":"456","article-title":"A pilot study on the liver protective effect of silybin-phosphatidylcholine complex (IdB1016) in chronic active hepatitis","volume":"31","author":"Buzzelli","year":"1993","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.dld.2006.11.004_bib30","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1053\/jhep.2000.18663","article-title":"Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid","volume":"32","author":"Angulo","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2006.11.004_bib31","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1053\/jhep.2001.22340","article-title":"Clinical studies with silymarin: fibrosis progression is the end point","volume":"33","author":"Schuppan","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2006.11.004_bib32","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/(SICI)1099-081X(199711)18:8<717::AID-BDD54>3.0.CO;2-U","article-title":"The pharmacokinetics of glycyrrhizin and its restaurative effect on hepatic function in patients with chronic hepatitis and in chronically carbon-tetrachloride-intoxicated rats","volume":"18","author":"Yamamura","year":"1997","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.dld.2006.11.004_bib33","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0168-8278(94)80108-8","article-title":"Effects of glycyrrhizin on hepatitis B surface antigen: a biochemical and morphological study","volume":"21","author":"Takahara","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2006.11.004_bib34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1365-2036.1998.00309.x","article-title":"Review article: glycyrrhizin as a potential treatment for chronic hepatitis C","volume":"12","author":"Van Rossum","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2006.11.004_bib35","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1600-0676.1998.tb00147.x","article-title":"Inhibitory effect of glycyrrhizin on NF-kappa B binding activity in CCL4-plus ethanol-induced liver cirrhosis in rats","volume":"18","author":"Wang","year":"1998","journal-title":"Liver"},{"key":"10.1016\/j.dld.2006.11.004_bib36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1440-1746.1992.tb00927.x","article-title":"Effect of glycyrrhizin on lysis of hepatocyte membranes induced by anti-liver cell membrane antibody","volume":"7","author":"Shiki","year":"1992","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2006.11.004_bib37","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/BF02782862","article-title":"Glycyrrhizin withdrawal followed by human lymphoblasoid interferon in the treatment of chronic hepatitis B","volume":"26","author":"Hayashi","year":"1991","journal-title":"Gastroenterol Jpn"},{"key":"10.1016\/j.dld.2006.11.004_bib38","first-page":"1817","article-title":"Effectiveness of interferon, glycyrrhizin combination therapy in patients with chronic hepatitis C","volume":"52","author":"Abe","year":"1994","journal-title":"Nippon Rinsho"},{"key":"10.1016\/j.dld.2006.11.004_bib39","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1494::AID-CNCR8>3.0.CO;2-B","article-title":"The long-term efficacy of glycyrrhizin in chronic hepatitis C patients","volume":"79","author":"Arase","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2006.11.004_bib40","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jhep.2003.11.014","article-title":"Complementary and alternative therapies in the treatment of chronic hepatitis C: a systematic review","volume":"40","author":"Thompson Coon","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2006.11.004_bib41","first-page":"1495","article-title":"Treatment of chronic active hepatitis C with interferon alpha 2b alone and in combination with Stronger Neo Minophagen C","volume":"12","author":"Fujiyama","year":"1998","journal-title":"Biother Jpn"},{"key":"10.1016\/j.dld.2006.11.004_bib42","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2957\/kanzo.37.363","article-title":"A prospective randomised administration of Atronge Neo Minophagen C as an adjuvant therapy for chronic hepatitis type C treated with interferon","volume":"37","author":"Suzuki","year":"1996","journal-title":"Acta Hepatol Jpn"},{"key":"10.1016\/j.dld.2006.11.004_bib43","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1046\/j.1440-1746.1999.02008.x","article-title":"Intraveouns glycyrrhizin for the treatment of chronic hepatitis C: a double-blind, randomised, placebo-controlled phase I\/II trial","volume":"14","author":"Van Rossum","year":"1999","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2006.11.004_bib44","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/00042737-199910000-00002","article-title":"Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection: a randomized controlled trial in 170 patients","volume":"11","author":"Tsubota","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2006.11.004_bib45","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/S0002-9270(01)02612-0","article-title":"Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C","volume":"96","author":"Van Rossum","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2006.11.004_bib46","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1386-6346(99)00047-9","article-title":"Therapeutic effects of stronger Neo-Minophagen C (SNMC) in patients with chronic liver disease","volume":"16","author":"Zhang","year":"2000","journal-title":"Hepatol Res"},{"key":"10.1016\/j.dld.2006.11.004_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1386-6346(00)00123-6","article-title":"Treatment of subacute hepatitis with lamivudine and intravenous glycyrrhizin: a pilot study","volume":"20","author":"Tandon","year":"2001","journal-title":"Hepatol Res"},{"key":"10.1016\/j.dld.2006.11.004_bib48","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1386-6346(02)00086-4","article-title":"Randomized clinical trial with two doses (100 and 40ml) of stronger Neo-Minophagen C in Chinese patients with chronic hepatitis B","volume":"24","author":"Zhang","year":"2002","journal-title":"Hepatol Res"},{"key":"10.1016\/j.dld.2006.11.004_bib49","first-page":"69","article-title":"A preliminary open trial on interferon stimulator (SNMC) derived from glycyrrhiza glabra in the treatment of subacute hepatic failure","volume":"98","author":"Acharya","year":"1993","journal-title":"Ind J Med Res"},{"key":"10.1016\/j.dld.2006.11.004_bib50","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1507\/endocrj1954.38.103","article-title":"Renin-dependency of glycyrrhizin-induced pseudohyperaldosteronism","volume":"38","author":"Kageyama","year":"1991","journal-title":"Endocrinol Jpn"},{"key":"10.1016\/j.dld.2006.11.004_bib51","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/(SICI)1098-1128(199807)18:4<225::AID-MED2>3.0.CO;2-X","article-title":"A review of the plants of the genus Phyllanthus: their chemistry, pharmacology, and therapeutic potential","volume":"18","author":"Calixto","year":"1998","journal-title":"Med Res Rev"},{"key":"10.1016\/j.dld.2006.11.004_bib52","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1073\/pnas.84.1.274","article-title":"Effects of an extract from Phyllanthus niruri on hepatitis B virus and woodchuck hepatitis viruses: in vitro and in vivo studies","volume":"84","author":"Venateswaran","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.dld.2006.11.004_bib53","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0166-3542(95)00020-M","article-title":"Differential inhibition of reverse transcriptase and cellular DNA polymerase-alpha activities by lignans isolated from Chinese herbs, Phyllanthus myrtifolius Moon, and tannins from Lonicera japonica Thumb and Castanopsis hystrix","volume":"27","author":"Chang","year":"1995","journal-title":"Antiviral Res"},{"key":"10.1016\/j.dld.2006.11.004_bib54","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1046\/j.1365-2362.1996.410595.x","article-title":"Phyllanthus amarus down-regulates hepatitis B virus mRNA transcription and replication","volume":"26","author":"Lee","year":"1996","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.dld.2006.11.004_bib55","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1046\/j.1365-2362.1997.2020749.x","article-title":"Phyllanthus amarus suppresses hepatitis B virus by interrupting interactions between HBV enhancer I and cellular transcription factors","volume":"27","author":"Ott","year":"1997","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.dld.2006.11.004_bib56","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1046\/j.1365-2893.2001.00307.x","article-title":"Genus Phyllanthus for chronic hepatitis B virus infection: a systematic review","volume":"8","author":"Liu","year":"2001","journal-title":"J Viral Hep"},{"key":"10.1016\/j.dld.2006.11.004_bib57","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0140-6736(88)92416-6","article-title":"Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus","volume":"2","author":"Thyagarajan","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2006.11.004_bib58","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0168-8278(91)90850-B","article-title":"Beneficial effects of Phyllanthus amarus for chronic hepatitis B, not confirmed (letter)","volume":"12","author":"Berk","year":"1991","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2006.11.004_bib59","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/0140-6736(90)91436-E","article-title":"Failure of Phyllanthus amarus to eradicate hepatitis B surface antigen from symptomless carriers","volume":"335","author":"Leelarasamee","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2006.11.004_bib60","first-page":"243","article-title":"Failure of New Zealand hepatitis B carriers to respond to Phyllanthus amarus","volume":"107","author":"Milne","year":"1994","journal-title":"NZ Med J"},{"key":"10.1016\/j.dld.2006.11.004_bib61","first-page":"381","article-title":"Efficacy of Phyllanthus amarus for eradication of hepatitis B virus in chronic carriers","volume":"74","author":"Thamlikitkul","year":"1991","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.dld.2006.11.004_bib62","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0140-6736(90)92328-F","article-title":"Phyllanthus amarus and hepatitis B","volume":"336","author":"Thyagarajan","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2006.11.004_bib63","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1136\/bmj.323.7320.1071a","article-title":"Bias in alternative medicine is still rife but is diminishing","volume":"323","author":"Schmidt","year":"2001","journal-title":"Br Med J"},{"key":"10.1016\/j.dld.2006.11.004_bib64","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0197-2456(97)00150-5","article-title":"Do certain countries produce only positive results? A systematic review of controlled trails","volume":"19","author":"Vickers","year":"1998","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.dld.2006.11.004_bib65","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0168-8278(98)80161-X","article-title":"Inhibitory effects of the herbal medicine Sho-saiko-to (TJ-9) on cell proliferation and procollagen expressions in cultured rat hepatic cells","volume":"29","author":"Kayano","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2006.11.004_bib66","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-2999(99)00418-5","article-title":"Strong antiproliferative effects of baicalein in cultured rat hepatic stellate cells","volume":"378","author":"Inoue","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.dld.2006.11.004_bib67","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0168-8278(88)80017-5","article-title":"Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet","volume":"28","author":"Sakaida","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2006.11.004_bib68","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1211\/0022357991773429","article-title":"Effects of Sho-saiko-to extract on liver fibrosis in relation to the changes in hydroxyproline and retinoid levels of the liver in rats","volume":"51","author":"Ono","year":"1999","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.dld.2006.11.004_bib69","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/hep.510290108","article-title":"Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats","volume":"29","author":"Shimizu","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2006.11.004_bib70","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/1097-0142(19950901)76:5<743::AID-CNCR2820760506>3.0.CO;2-V","article-title":"Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9)","volume":"76","author":"Oka","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2006.11.004_bib71","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1053\/jhep.2002.33066","article-title":"Effects of Sho saiko-to in hepatocarcinogenesis and 8-hydroxy-2\u2032-deoxyguanosine formation","volume":"35","author":"Shiota","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2006.11.004_bib72","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0162-3109(99)00034-X","article-title":"The restoration of the antitumor T cell response from stress-induced suppression using a traditional Chinese herbal medicine Hochu-ekki-to (TJ-41: Bu-Zhong-Yi-Qi-Tang)","volume":"43","author":"Li","year":"1999","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.dld.2006.11.004_bib73","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1142\/S0192415X00000416","article-title":"Clinical and pharmacological studies on liver diseases treated with Kampo herbal medicine","volume":"28","author":"Cyong","year":"2000","journal-title":"Am J Chin Med"},{"key":"10.1016\/j.dld.2006.11.004_bib74","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1440-1746.1998.tb00662.x","article-title":"Liver in traditional Chinese medicine","volume":"13","author":"Chen","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2006.11.004_bib75","first-page":"189","article-title":"Liver-protective activities of aucubin derived from traditional oriental medicine","volume":"102","author":"Chang","year":"1998","journal-title":"Res Commun Mol Pathol Pharmacol"},{"key":"10.1016\/j.dld.2006.11.004_bib76","unstructured":"Chang IM. Antiviral activities of aucubin derived from traditional Chinese herbs in HepG2, woodchucks and humans infected with hepatitis B. Complementary and Alternative Medicine in Chronic Liver Disease. Submitted abstract, p65, 1999."},{"key":"10.1016\/j.dld.2006.11.004_bib77","first-page":"214","article-title":"The effect of herbal compound 861 on mRNA levels for type I, III, and IV collagens and TGF in immune complex rat liver fibrosis","volume":"4","author":"Jia","year":"1996","journal-title":"Chin J Hepatol"},{"key":"10.1016\/j.dld.2006.11.004_bib78","first-page":"142","article-title":"The effect of herbal cpd 861 on type IV collagen mRNA levels in cultured rat lipocytes","volume":"4","author":"Jia","year":"1996","journal-title":"Chin J Hepatol"},{"key":"10.1016\/j.dld.2006.11.004_bib79","first-page":"4","article-title":"Long-term follow-up result of compound Dan Shen granule (861 Chong Fu Ji) in treating hepatofibrosis","volume":"5","author":"Wang","year":"1995","journal-title":"Chin J Integr Trad West Med"},{"key":"10.1016\/j.dld.2006.11.004_bib80","first-page":"148","article-title":"Pathological study of the therapeutic effect on HBV-related liver fibrosis with herbal compound 861","volume":"7","author":"Wang","year":"1998","journal-title":"Chin J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2006.11.004_bib81","doi-asserted-by":"crossref","unstructured":"Baoen W. Experimental and clinical study in inhibition and reversal of liver fibrosis with integrated Chinese and Western medicine. Complementary and alternative Medicine in Chronic Liver Disease, submitted abstract, p63, 1999.","DOI":"10.1007\/BF02934179"},{"key":"10.1016\/j.dld.2006.11.004_bib82","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1440-1746.1998.01550.x","article-title":"Preliminary report of a randomized, double-blind placebo-controlled trial of a Chinese herbal medicine preparation CH100 in the treatment of chronic hepatitis C","volume":"13","author":"Batey","year":"1998","journal-title":"J Gastroenterol Hepatzol"},{"key":"10.1016\/j.dld.2006.11.004_bib83","first-page":"694","article-title":"Hepatoprotective effect of LIV.52 against CCl4-induced lipid peroxidation in liver of rats","volume":"32","author":"Pandey","year":"1994","journal-title":"Int J Exp Biol"},{"key":"10.1016\/j.dld.2006.11.004_bib84","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-8741(02)00263-5","article-title":"Liv 52 in alcoholic liver disease: a prospective, controlled trial","volume":"84","author":"de Silva","year":"2003","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.dld.2006.11.004_bib85","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.phymed.2004.10.003","article-title":"The efficacy of Liv-52 on liver cirrhotic patients: a randomized, double-blind, placebo-controlled first approach","volume":"12","author":"Huseini","year":"2005","journal-title":"Phytomedicine"},{"key":"10.1016\/j.dld.2006.11.004_bib86","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF00280076","article-title":"Effect of LIV.52, a herbal preparation, on absorbtion and metabolism of ethanol in humans","volume":"40","author":"Chauhan","year":"1991","journal-title":"Eur J Clin Pharmacol"},{"issue":"suppl. 1","key":"10.1016\/j.dld.2006.11.004_bib87","first-page":"127","article-title":"and a European multicenter study group. The ayurvedic drug LIV. 52 in patients with alcoholic cirrhosis. Results of a prospective, randomized, double-blind, palcebo-controlled clinical trial (abstract)","volume":"26","author":"Fleig","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2006.11.004_bib88","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/hep.510270512","article-title":"Effect of antioxidants, resveratrol, quercetin, an N-acetylcysteine, on the functions of cultured hepatic stellate cells and Kupffer cells","volume":"27","author":"Kawada","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2006.11.004_bib89","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1053\/he.2000.5848","article-title":"Deactivation of cultured human liver myofibroblasts by trans-reseveratrol, a grapevine-derived polyphenol","volume":"31","author":"Godichaud","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2006.11.004_bib90","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jhep.2005.08.002","article-title":"Herbal hepatotoxicity","volume":"43","author":"Stickel","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2006.11.004_bib91","doi-asserted-by":"crossref","first-page":"729","DOI":"10.7326\/0003-4819-121-10-199411150-00001","article-title":"Acute hepatitis associated with the Chinese herbal product Jin Bu Huan","volume":"10","author":"Woolf","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2006.11.004_bib92","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0168-8278(98)80217-1","article-title":"Chronic hepatitis induced by Jin Bu Huan","volume":"28","author":"Picciotto","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2006.11.004_bib93","first-page":"1436","article-title":"Acute hepatitis associated with the use of a Chinese herbal product, Ma-Huang","volume":"91","author":"Nadir","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2006.11.004_bib94","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00042737-200505000-00017","article-title":"Ma huang associated acute liver failure requiring liver transplantation","volume":"17","author":"Skoulidis","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2006.11.004_bib95","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1023\/A:1026105917735","article-title":"The irony of herbal hepatitis: Ma-Huang-induced hepatotoxicity associated with compound heterozygosity for hereditary hemochromatosis","volume":"48","author":"Bajaj","year":"2003","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2006.11.004_bib96","first-page":"38","article-title":"Chinese herbs for eczema","volume":"336","author":"Davies","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2006.11.004_bib97","first-page":"674","article-title":"Toxicity of Chinese herbal remedies","volume":"346","author":"Graham-Brown","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2006.11.004_bib98","first-page":"674","article-title":"Toxicity of traditional Chinese herbal remedies","volume":"346","author":"Perharic-Walton","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2006.11.004_bib99","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/gut.36.1.146","article-title":"Hepatitis induced by traditional Chinese herbs; possible toxic components","volume":"36","author":"Kane","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.dld.2006.11.004_bib100","first-page":"2647","article-title":"Chinese herbal medicine, fulminant hepatitis and liver transplantation","volume":"12","author":"Yoshida","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2006.11.004_bib101","first-page":"828","article-title":"Senecio disease or cirrhosis of the liver due to senecio poisoning","volume":"II","author":"Wilmot","year":"1920","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2006.11.004_bib102","first-page":"285","article-title":"Veno-occlusive disease of the liver with non-portal type of cirrhosis occurring in Jamaica","volume":"57","author":"Bras","year":"1954","journal-title":"Arch Pathol"},{"key":"10.1016\/j.dld.2006.11.004_bib103","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(76)90727-3","article-title":"An epidemic of veno-occlusive disease of liver in Central India","volume":"2","author":"Tandon","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2006.11.004_bib104","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/pgmj.54.634.511","article-title":"Herbal medicine and veno-occlusive disease in India","volume":"54","author":"Datta","year":"1978","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.dld.2006.11.004_bib105","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0016-5085(19)32224-3","article-title":"Hepatic veno-occlusive disease due to pyrrolizidine (Senecio) poisoning in Arizona","volume":"73","author":"Stillman","year":"1977","journal-title":"Gastroentrology"},{"key":"10.1016\/j.dld.2006.11.004_bib106","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0022-3476(78)81227-X","article-title":"Pyrrolizidine (Senecio) intoxication mimicking Reye's syndrome","volume":"93","author":"Fox","year":"1978","journal-title":"J Pediatr"},{"key":"10.1016\/j.dld.2006.11.004_bib107","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/bmj.295.6591.183","article-title":"Veno-occlusive disease of the liver secondary to ingestion of comfrey","volume":"295","author":"Weston","year":"1987","journal-title":"Br Med J"},{"key":"10.1016\/j.dld.2006.11.004_bib108","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0022-3476(88)80330-5","article-title":"Hepatic veno-occlusive disease in a newborn infant of a woman drinking herbal tea","volume":"112","author":"Roulet","year":"1988","journal-title":"J Pediatr"},{"key":"10.1016\/j.dld.2006.11.004_bib109","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2002-23204","article-title":"Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease)","volume":"22","author":"DeLeve","year":"2002","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.dld.2006.11.004_bib110","first-page":"1006","article-title":"H\u00e9patite aigue \u00e0 la Germandr\u00e9e petit-chene","volume":"16","author":"Diaz","year":"1993","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.dld.2006.11.004_bib111","doi-asserted-by":"crossref","first-page":"129","DOI":"10.7326\/0003-4819-117-2-129","article-title":"Hepatitis after Germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity","volume":"117","author":"Larrey","year":"1992","journal-title":"Ann Int Med"},{"key":"10.1016\/j.dld.2006.11.004_bib112","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/0140-6736(92)92209-X","article-title":"Fatal hepatitis after herbal tea","volume":"340","author":"Mostefa-Kara","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2006.11.004_bib113","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1055\/s-2007-1007276","article-title":"Hepatotoxicity of herbal remedies and mushrooms","volume":"15","author":"Larrey","year":"1995","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.dld.2006.11.004_bib114","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/gast.1997.v113.pm9322529","article-title":"Diterpenoids from germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes","volume":"113","author":"Fau","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2006.11.004_bib115","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0168-8278(95)80458-7","article-title":"Liver transplantation for severe acute liver failure after herbal medicine (Teucrium polium) administration","volume":"22","author":"Mattei","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2006.11.004_bib116","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/phrs.1996.0019","article-title":"Pharmacological activities of Chelidonium majus L. (Papaveraceae)","volume":"33","author":"Colombo","year":"1996","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.dld.2006.11.004_bib117","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1055\/s-2007-1024196","article-title":"Necrotizing hepatitis after taking herbal medication extracts of kava or of common or lesser celandine (article in German)","volume":"123","author":"Strahl","year":"1998","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.dld.2006.11.004_bib118","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1002\/(SICI)1099-1557(199808)7:1+<S66::AID-PDS349>3.3.CO;2-7","article-title":"Chelidonium majus: a rare reason for severe hepatotoxic reaction","volume":"7","author":"Greving","year":"1998","journal-title":"Pharmaepidemiol Drug Saf"},{"key":"10.1016\/j.dld.2006.11.004_bib119","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0016-5085(99)70410-5","article-title":"Acute hepatitis induced by greater celandine (Chelidonium majus)","volume":"117","author":"Benninger","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2006.11.004_bib120","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/00365520310000942","article-title":"Acute hepatitis induced by greater celandine","volume":"38","author":"Stickel","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2006.11.004_bib121","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/00004714-200002000-00014","article-title":"Efficacy of kava extract for treating anxiety: systematic review and meta-analysis","volume":"20","author":"Pittler","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.dld.2006.11.004_bib122","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0168-8278(03)00175-2","article-title":"Hepatitis induced by Kava-Kava (Piper methysticum rhizoma)","volume":"39","author":"Stickel","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2006.11.004_bib123","doi-asserted-by":"crossref","first-page":"68","DOI":"10.7326\/0003-4819-135-1-200107030-00036","article-title":"Kava hepatotoxicity","volume":"135","author":"Russmann","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2006.11.004_bib124","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1001\/archinte.1991.00400110123024","article-title":"The use of medicinal herbs by human immunodeficiency virus-infected patients","author":"Kassler","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.dld.2006.11.004_bib125","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archinte.1997.00440290099011","article-title":"Chaparral-associated Hepatotoxicity","volume":"157","author":"Sheikh","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.dld.2006.11.004_bib126","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0168-8278(97)82333-1","article-title":"Hepatotoxicity of herbal remedies","volume":"26","author":"Larrey","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2006.11.004_bib127","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00007691-200012000-00001","article-title":"The biochemistry and toxicity of atractyloside: a review","volume":"22","author":"Stewart","year":"2000","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.dld.2006.11.004_bib128","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0140-6736(91)91012-J","article-title":"Hepatitis after chronic abuse of senna","volume":"337","author":"Beuers","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2006.11.004_bib129","first-page":"567","article-title":"Menthofuran-dependent and independent aspects of pulegone hepatotoxicity: roles of glutathione","volume":"253","author":"Thomassen","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.dld.2006.11.004_bib130","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/0003-4819-124-8-199604150-00004","article-title":"Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature","volume":"124","author":"Anderson","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2006.11.004_bib131","doi-asserted-by":"crossref","first-page":"68","DOI":"10.7326\/0003-4819-144-1-200601030-00020","article-title":"Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis)","volume":"144","author":"Bonkovsky","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2006.11.004_bib132","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7326\/0003-4819-127-2-199707150-00033","article-title":"Protracted cholestatic hepatitis after the use of prostata","volume":"127","author":"Hamid","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2006.11.004_bib133","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00042737-200504000-00009","article-title":"Herbal hepatotoxicity: acute hepatitis caused by a Noni preparation (Morinda citrifolia)","volume":"17","author":"Millonig","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2006.11.004_bib134","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/lt.20778","article-title":"Fulminant hepatic failure associated with the use of Black Cohosh: a case report","volume":"12","author":"Lynch","year":"2006","journal-title":"Liver Transpl"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865806005974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865806005974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T20:42:25Z","timestamp":1683751345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865806005974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":134,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S1590865806005974"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2006.11.004","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}